If a company can't hold up to being criticized, then it's certainly a questionable investment worthy of criticism. If I'm supposed to gauge the value of this company based on the performance over the past three years I'm afraid that's far more a disservice to shareholders done by the CEO herself than anything I've said. How much has an investment lost in three years? How about the past 4 months? I'm not impressed and I'm especially not impressed by anything that has no bearing on RXSF's bottom line. I see flip potential and that's about it until Lorraine can come up with something better than a $50-100,000 order financed with $150,000 in toxic lending and a $10,000,000 equity line of credit.
